Solved Case Analysis: Arcadian Microarray Technologies, Inc. by Robert F. Bruner, Sean Carr

Get the Best Analysis to this Case Study written by MBA/CFA writers.

**Order Now by just sending an email at assignment@writerkingdom.com . Send us case study file and questions which you want to get covered in case solution. Click Here to see how it works

Compare

Description

In August 2005, an investment manager of a hedge fund is considering purchasing an equity interest in a start-up biotechnology firm, Arcadian Microarray Technologies, Inc. The asking price is $40 million for a 60 percent equity interest. Managers of the firm are optimistic about the firm’s future performance; the investment manager is more conservative in his expectations. He calls on the help of an analyst with her firm to fashion a counterproposal to Arcadian’s management. The tasks for the student are to apply the concept of terminal value, interpret completed analyses and data, and derive implications of different terminal-value assumptions in an effort to recommend a counterproposal. Very little numerical figure-work is required of the student.

Publishing Authority:

Darden Business Publishing – University of Virginia

Reviews

There are no reviews yet.

Be the first to review “Solved Case Analysis: Arcadian Microarray Technologies, Inc. by Robert F. Bruner, Sean Carr”

Your email address will not be published. Required fields are marked *